X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Why You Should Care

  • Each year cancer (overall) kills 14 million people worldwide
  • Men are more likely than women to be diagnosed with some type of cancer during their lifetime (50 percent of men compared to 33 percent of women)
  • Prostate cancer is the most common non-skin cancer in the U.S., affecting one in six men
  • African American men have the highest incidence of prostate cancer and are 60 percent more likely to develop the disease compared to Caucasian men
  • Men with a family history of prostate cancer are at higher risk for developing prostate cancer
  • Every year more than 230,000 men are diagnosed with prostate cancer; this number increases annually as the general population of aging men increases
  • Prostate cancer is the second largest cancer killer of men following lung cancer; approximately 30,000 men will die this year from prostate cancer (82 men every day)
  • Screening for prostate cancer includes a PSA (prostate specific antigen) blood test and a DRE (digital rectal exam); a biopsy is required to diagnose prostate cancer
  • There is confusion over inconsistent messages about the value of PSA testing for prostate cancer; we fear that this is causing some men to forego testing for early detection resulting in physicians seeing an increase in prostate cancer initially diagnosed at an advanced stage
  • Rather than any “quick fix” for prostate cancer, there are many treatment options and related side effects that each patient needs to evaluate